Researchers have identified a molecular switch that appears to be a common feature in the development of fatty liver disease. The discovery made in mice is consistent with data from human patients, suggesting that it may ...
Differences in the levels of two key metabolic enzymes may explain why some people are more susceptible to liver damage, according to a study in the October 17 issue of the Journal of Cell Biology.
US regulators on Friday approved the first new treatment for hepatitis C in more than a decade, a Merck pharmaceutical known as Victrelis, to be taken with the current two-drug regimen.
Germany called crisis talks Monday over warnings that an outbreak of E. coli bacteria poisoning, which is believed to have already left 10 dead, was still spreading.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a process that controls the amount of fat that cells store for use as a back-up energy source. Disruption of this process allows cellular ...
The pharmaceutical giant Pfizer will voluntarily suspend US sales of a poultry-pumping additive after studies showed it can leave traces of arsenic in chicken livers, the US government said on Wednesday.
The number of E. coli poisoning cases in Sweden rose to 39 on Monday, 15 of which are serious, health officials said.
The US Food and Drug Administration on Monday approved Incivek to treat hepatitis C when taken along with the current two-drug regimen, marking the second such drug approval this month.
University of Queensland Diamantina Institute PhD student, Veronique Chachay, hopes to determine if a nutrient found in grape skin could hold the key to better managing non-alcoholic fatty liver disease (NAFLD).
NAFLD is a condition where fat accumulates in the liver (steatosis) and can lead to liver inflammation (nonalcoholic steatohepatitis or NASH) and permanent liver damage (fibrosis/cirrhosis). NAFLD affects anywhere from 11% ...